Synthesis and use of enantiomerically pure tert-leucine

被引:183
作者
Bommarius, AS [1 ]
Schwarm, M [1 ]
Stingl, K [1 ]
Kottenhahn, M [1 ]
Huthmacher, K [1 ]
Drauz, K [1 ]
机构
[1] DEGUSSA AG, ORGAN CHEM R&D ICFE, D-63403 HANAU, GERMANY
关键词
D O I
10.1016/0957-4166(95)00377-0
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Owing to its bulky, inflexible and hydrophobic tert-butyl side chain, tert-leucine (Tle) finds increased use in templates or catalysts in asymmetric synthesis as well as in peptidic medicinal compounds. (S)-Tle, available through a large-scale enzymatic reductive amination process, has been incorporated into a variety of anti-AIDS and -cancer compounds. With two new routes to (R)-Tle coming available, the number of applications of both (R)- and (S)-Tle can be expected to increase considerably.
引用
收藏
页码:2851 / 2888
页数:38
相关论文
共 189 条